Scott A. Smith

2015

In 2015, Scott A. Smith earned a total compensation of $4.8M as President, Immunology & Inflammation at Celgene, a 46% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$860,433
Option Awards$1,189,715
Salary$641,667
Stock Awards$2,072,789
Other$18,641
Total$4,783,245

Smith received $2.1M in stock awards, accounting for 43% of the total pay in 2015.

Smith also received $860.4K in non-equity incentive plan, $1.2M in option awards, $641.7K in salary and $18.6K in other compensation.

Rankings

In 2015, Scott A. Smith's compensation ranked 1,700th out of 13,638 executives tracked by ExecPay. In other words, Smith earned more than 87.5% of executives.

ClassificationRankingPercentile
All
1,700
out of 13,638
88th
Division
Manufacturing
613
out of 5,190
88th
Major group
Chemicals And Allied Products
224
out of 1,854
88th
Industry group
Drugs
173
out of 1,528
89th
Industry
Pharmaceutical Preparations
138
out of 1,182
88th
Source: SEC filing on April 28, 2016.

Smith's colleagues

We found five more compensation records of executives who worked with Scott A. Smith at Celgene in 2015.

2015

Robert Hugin

Celgene

Chief Executive Officer

2015

Jacqualyn Fouse

Celgene

President Hematology and Oncology

2015

Mark Alles

Celgene

Chief Operating Officer

2015

Thomas Daniel

Celgene

Chairman

2015

Peter Kellogg

Celgene

Chief Financial Officer

You may also like